Immediate Impact
2 by Nobel laureates 26 from Science/Nature 99 standout
Citing Papers
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2023 Standout
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
2023 StandoutNature
Works of Nicholas Iannotti being referenced
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy
2023
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nicholas Iannotti | 3141 | 1281 | 117 | 1307 | 58 | 3.8k | |
| P. Murawa | 2960 | 1140 | 296 | 1063 | 48 | 4.1k | |
| Françoise Farace | 1902 | 826 | 92 | 1161 | 92 | 3.3k | |
| Matthew Krebs | 3876 | 1786 | 97 | 2127 | 151 | 5.3k | |
| George N. Naumov | 2288 | 1324 | 193 | 1136 | 37 | 3.9k | |
| Tim Ward | 2320 | 993 | 119 | 1488 | 40 | 3.4k | |
| Nikolas H. Stoecklein | 2858 | 911 | 158 | 1856 | 115 | 4.5k | |
| Ibiayi Dagogo‐Jack | 1901 | 1790 | 314 | 1287 | 83 | 4.2k | |
| Peter Vermeulen | 2257 | 753 | 299 | 1244 | 76 | 3.9k | |
| Marjolijn N. Lub–de Hooge | 2199 | 957 | 2873 | 466 | 99 | 4.8k | |
| Paola Gazzaniga | 1906 | 573 | 53 | 1147 | 111 | 3.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...